Barely 1 in seventeen genes, namely cyclin D3, experienced statistically significant difference between AML and CML, in the CD34 positive fraction (Fig 1). The gene discussed is CCND3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.